GGrantIndex
← Leaderboards

Jill A. Macoska

University Of Michigan At Ann Arbor

$8,042,481
Attributed
$8,732,900
Total exposure
21
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,268,169 · 22

By mechanism

U54$20,992,105 · 11
R01$2,248,796 · 2
P30$1,143,233 · 3
R21$730,979 · 2
P20$596,848 · 1
T32$332,589 · 1

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseUniversitiesResearch PersonnelGenomicsCancer CenterBostonMassachusettsCancer Health DisparityTrainingResearch DesignCellsResearch Project GrantsInnovationProgramsCommunitiesLaboratoriesDesignFacultyTechnologyStudentsEducation ResearchTissuesExperimental DesignsMediating

Grant awards (71)

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,525,000
U54 · FY2025 · CA
Genomics Core$134,909
U54 · FY2025 · CA · contact PI
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,448,749
U54 · FY2024 · CA
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$369,198
U54 · FY2024 · CA
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$325,963
U54 · FY2024 · CA
Genomics Core$200,410
U54 · FY2024 · CA · contact PI
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$200,000
U54 · FY2024 · CA
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,483,629
U54 · FY2023 · CA
Administrative Core$368,125
U54 · FY2023 · CA
Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility Mentorship at UMass Boston$368,125
U54 · FY2023 · CA
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$255,274
U54 · FY2023 · CA
Genomics Core$129,738
U54 · FY2023 · CA · contact PI
Persistence of an IL-4/IL-13 autocrine loop promotes fibrosis-mediated urinary voiding dysfunction$126,949
U54 · FY2023 · DK
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,494,500
U54 · FY2022 · CA
Genomics Core$131,859
U54 · FY2022 · CA · contact PI
Persistence of an IL-4/IL-13 autocrine loop promotes fibrosis-mediated urinary voiding dysfunction$126,949
U54 · FY2022 · DK
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,522,060
U54 · FY2021 · CA
Genomics Core$134,909
U54 · FY2021 · CA · contact PI
Persistence of an IL-4/IL-13 autocrine loop promotes fibrosis-mediated urinary voiding dysfunction$126,950
U54 · FY2021 · DK
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,694,042
U54 · FY2020 · CA
Shared Resource Core$148,783
U54 · FY2020 · CA · contact PI
Persistence of an IL-4/IL-13 autocrine loop promotes fibrosis-mediated urinary voiding dysfunction$90,335
U54 · FY2020 · DK
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,645,877
U54 · FY2019 · CA
Persistence of an IL-4/IL-13 autocrine loop promotes fibrosis-mediated urinary voiding dysfunction$166,371
U54 · FY2019 · DK
Shared Resource Core$156,800
U54 · FY2019 · CA · contact PI
Development of Biodegradable Liquid Metal Nanocarriers$90,514
U54 · FY2019 · CA
Environmental Carcinogens Drive Risk for Breast Cancer in BRCA2 Mutation Carriers$88,529
U54 · FY2019 · CA
SPRING: Smoking Protective and Riskc Factors in Transgender and Non conforming Groups$73,408
U54 · FY2019 · CA
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,691,502
U54 · FY2018 · CA
Shared Resource Core$149,438
U54 · FY2018 · CA · contact PI
CXCL12/CXCR4 Axis Activation in Lower Urinary Tract Fibrosis and Dysfunction$121,839
U54 · FY2018 · DK · contact PI
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$64,152
U54 · FY2018 · CA
Shared Resource Core$9,165
U54 · FY2018 · CA · contact PI
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,700,705
U54 · FY2017 · CA
Shared Resource Core$144,754
U54 · FY2017 · CA · contact PI
CXCL12/CXCR4 Axis Activation in Lower Urinary Tract Fibrosis and Dysfunction$95,966
U54 · FY2017 · DK · contact PI
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research$1,746,493
U54 · FY2016 · CA
Shared Resource Core$149,386
U54 · FY2016 · CA · contact PI
CXCL12/CXCR4 Axis Activation in Lower Urinary Tract Fibrosis and Dysfunction$121,840
U54 · FY2016 · DK · contact PI
CXCL12/CXCR4 Axis Activation in Lower Urinary Tract Fibrosis and Dysfunction$187,265
U54 · FY2015 · DK · contact PI
Fibrosis-Associated Urinary Gene Transcripts for LUTS Detection and Treatment$213,211
R21 · FY2014 · DK · contact PI
CXCL12/CXCR4 Axis Activation in Lower Urinary Tract Fibrosis and Dysfunction$181,645
U54 · FY2014 · DK · contact PI
Fibrosis-Associated Urinary Gene Transcripts for LUTS Detection and Treatment$216,600
R21 · FY2013 · DK · contact PI
Society for Basic Urologic Research Fall Symposium 2012$10,000
R13 · FY2012 · DK · contact PI
PTEN- and EGFR-Dependence of CXCL12-Mediated Proliferation in the Aging Prostate$321,779
R01 · FY2011 · DK · contact PI
Role of Prostatic Fibrosis in BPH/LUTS Development & Symptomology$298,424
P20 · FY2011 · DK · contact PI
PTEN- and EGFR-Dependence of CXCL12-Mediated Proliferation in the Aging Prostate$325,029
R01 · FY2010 · DK · contact PI
Role of Prostatic Fibrosis in BPH/LUTS Development & Symptomology$298,424
P20 · FY2010 · DK · contact PI
CORE--Affymetrix and cDNA Microarray$235,880
P30 · FY2010 · CA · contact PI
Microarray Core$69,954
P30 · FY2010 · AR · contact PI
PTEN- and EGFR-Dependence of CXCL12-Mediated Proliferation in the Aging Prostate$328,313
R01 · FY2009 · DK · contact PI
CORE--Affymetrix and cDNA Microarray$234,373
P30 · FY2009 · CA · contact PI
Microarray Core$69,668
P30 · FY2009 · AR · contact PI
PTEN- and EGFR-Dependence of CXCL12-Mediated Proliferation in the Aging Prostate$328,313
R01 · FY2008 · DK · contact PI
Urology Research Training Grant$192,112
T32 · FY2008 · DK · contact PI
CORE--Affymetrix and cDNA Microarray$130,015
P30 · FY2008 · CA · contact PI
Microarray Core$68,415
P30 · FY2008 · AR · contact PI
University of Michigan O'Brien Center for Urology Research$213,619
P50 · FY2007 · DK · contact PI
Urology Research Training Grant$140,477
T32 · FY2007 · DK · contact PI
CORE--Affymetrix and cDNA Microarray$130,015
P30 · FY2007 · CA · contact PI
Microarray Core$36,898
P30 · FY2007 · AR · contact PI
AFFYMETRIX$130,015
P30 · FY2006 · CA · contact PI
Microarray Core$38,000
P30 · FY2006 · AR · contact PI
Analysis of 8P Loss in Human Prostate Cancer$234,706
R01 · FY2004 · CA
Analysis of 8P Loss in Human Prostate Cancer$234,809
R01 · FY2003 · CA
A Model System for Human Prostate Tumorigenesis$150,576
R21 · FY2003 · DK
Analysis of 8P Loss in Human Prostate Cancer$237,825
R01 · FY2002 · CA
A Model System for Human Prostate Tumorigenesis$150,592
R21 · FY2002 · DK
CORE--CDNA MICROARRAY FACILITY$0
P30 · FY2002 · CA
Analysis of 8P Loss in Human Prostate Cancer$238,022
R01 · FY2001 · CA
CORE--CDNA MICROARRAY FACILITY$0
P30 · FY2001 · CA